Skip to main navigation Skip to search Skip to main content

CTU: A phase III, multicenter, double-blind, placebo-controlled study to assess the efficacy and safety of induction therapy with RO7790121 in patients with moderately to severely active ulcerative colitis

  • Leong, Rupert (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Armstrong, Emilia (Clinical Trial Unit Staff)
  • McHugh, Tracey (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleGA45330
StatusActive
Effective start/end date6/11/24 → 28/09/29